Journal article
The role of lnk (Sh2b3) in the regulation of jak-stat signalling in haematopoiesis
R Morris, L Butler, A Perkins, NJ Kershaw, JJ Babon
Pharmaceuticals | MDPI | Published : 2022
DOI: 10.3390/ph15010024
Open access
Abstract
LNK is a member of the SH2B family of adaptor proteins and is a non-redundant regulator of cytokine signalling. Cytokines are secreted intercellular messengers that bind to specific receptors on the surface of target cells to activate the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signalling pathway. Activation of the JAK-STAT pathway leads to proliferative and often inflammatory effects, and so the amplitude and duration of signalling are tightly controlled. LNK binds phosphotyrosine residues to signalling proteins downstream of cytokines and constrains JAK-STAT signalling. Mutations in LNK have been identified in a range of haematological and inflammatory dise..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council (NHMRC) in Australia (Project grant no. 1122999, Program grant no. 1113577), an NHMRC IRIISS Grant 9000220, a Victorian State Government Operational Infrastructure Scheme grant and a Cancer Council Victoria grant (no. 1183557). J.J.B. is supported by an NHMRC fellowship. L.B. is supported by an HSANZ Leukaemia Foundation Scholarship.